Skip to main content

Table 2 Associations of risk factors with incident CVD by age at onset

From: Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident cardiovascular disease

 

Incident CVD, adjusted sHR (95%CI)

P for interaction

At age < 55 y

At age 55 to 65 y

At age 65 to 75 y

At age ≥ 75 y

Clinical risk factors

 Current smoker

1.49(1.33–1.67)

1.28(1.18–1.38)

1.15(1.05–1.25)

1.08(0.91–1.29)

0.0006

 Current drinker

0.82(0.73–0.92)

0.74(0.68–0.80)

0.82(0.75–0.90)

0.85(0.75–0.96)

0.8373

 Physical inactivity

1.21(1.05–1.38)

1.12(0.97–1.31)

1.14(0.99–1.31)

1.12(1.00–1.28)

0.0844

 Hypertension

3.77(3.34–4.25)

2.61(2.41–2.82)

2.27(2.08–2.48)

1.59(1.43–1.78)

 < 0.0001

 Diabetes

4.08(3.47–4.80)

2.35(2.13–2.59)

2.08(1.87–2.31)

1.36(1.18–1.58)

 < 0.0001

 Dyslipidemia

1.62(1.45–1.82)

1.35(1.25–1.46)

1.25(1.15–1.35)

1.12(1.01–1.25)

 < 0.0001

 Metabolism syndrome

3.38(2.94–3.88)

2.22(2.03–2.42)

1.77(1.61–1.94)

1.40(1.24–1.58)

 < 0.0001

 BMI, per SD increment

1.30(1.25–1.36)

1.24(1.20–1.29)

1.10(1.06–1.15)

1.12(1.06–1.17)

 < 0.0001

 Overweight or obese

1.71(1.52–1.92)

1.42(1.31–1.53)

1.19(1.10–1.29)

1.19(1.07–1.32)

 < 0.0001

 Systolic BP, per SD increment

2.22(2.12–2.34)

1.73(1.67–1.78)

1.58(1.52–1.63)

1.24(1.18–1.30)

 < 0.0001

 Diastolic BP, per SD increment

1.88(1.80–1.96)

1.47(1.42–1.51)

1.27(1.22–1.32)

1.09(1.03–1.15)

 < 0.0001

Lipids, per SD increment

 Total cholesterol

1.33(1.27–1.38)

1.10(1.06–1.14)

1.07(1.03–1.12)

1.07(1.02–1.13)

 < 0.0001

 Triglycerides

1.15(1.11–1.19)

1.10(1.07–1.13)

1.08(1.05–1.12)

1.09(1.03–1.15)

0.0193

 LDL cholesterol

1.05(0.98–1.14)

1.01(0.97–1.06)

1.04(1.00–1.08)

1.03(0.99–1.08)

0.8382

 HDL cholesterol

1.14(1.07–1.21)

1.04(1.00–1.09)

1.04(1.00–1.08)

0.98(0.93–1.03)

0.0023

 Total/HDL cholesterol

1.03(1.01–1.05)

1.04(1.00–1.07)

1.00(0.99–1.01)

1.01(1.00–1.02)

0.0549

 Triglycerides/HDL cholesterol

1.01(1.00–1.01)

1.14(1.09–1.19)

1.07(1.03–1.11)

1.04(1.01–1.07)

 < 0.0001

 Non–HDL cholesterol

1.32(1.26–1.38)

1.09(1.05–1.13)

1.06(1.01–1.10)

1.08(1.03–1.14)

 < 0.0001

 Remnant cholesterol

1.31(1.25–1.38)

1.08(1.04–1.12)

1.02(0.98–1.06)

1.05(0.99–1.10)

 < 0.0001

Metabolic, per SD increment

 Fasting blood glucose

1.31(1.24–1.38)

1.22(1.19–1.25)

1.16(1.13–1.19)

1.09(1.05–1.14)

 < 0.0001

 Triglyceride-glucose index

1.42(1.35–1.49)

1.26(1.22–1.31)

1.19(1.15–1.24)

1.14(1.09–1.21)

 < 0.0001

 eGFR

0.78(0.73–0.83)

0.79(0.75–0.84)

0.74(0.67–0.81)

0.96(0.85–1.09)

0.0030

 Creatinine

1.00(0.93–1.06)

1.04(1.01–1.07)

1.07(1.04–1.11)

1.04(1.00–1.08)

0.1459

 Serum uric acid

1.14(1.08–1.21)

1.10(1.05–1.14)

1.18(1.13–1.23)

1.07(1.02–1.12)

0.0076

Inflammatory, per SD increment

 Hs–CRP

1.12(1.08–1.17)

1.03(1.01–1.05)

1.06(1.03–1.09)

1.03(1.00–1.05)

0.0001

 White blood cell count

1.07(1.01–1.12)

1.00(0.99–1.01)

1.02(0.99–1.04)

0.97(0.94–1.00)

0.1470

 Neutrophil count

1.07(1.05–1.10)

1.03(1.01–1.04)

1.06(1.04–1.09)

1.00(0.97–1.03)

0.0248

 Platelet

1.00(0.99–1.00)

0.44(0.28–0.69)

0.68(0.37–1.24)

0.96(0.55–1.65)

0.0022

 Red blood cell count

0.00(0.00–0.86)

1.01(0.98–1.04)

1.01(0.98–1.04)

0.97(0.94–1.00)

0.0708

  1. sHRs (95% CI) were obtained from stratified competing risk models with non-CVD death as a competing risk, adjusted for gender, educational level, and family income, and interactions between the risk factors of interest and age groups
  2. CI Confidence interval, CVD Cardiovascular disease, eGFR Estimated glomerular filtration rate, HDL High-density lipoprotein, hs-CRP High-sensitivity C-reactive protein, LDL Low-density lipoprotein, SD Standard deviation, sHR Sub-distributional hazard ratio